Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Is tigecycline's liver safety affected by hepatic impairment?

See the DrugPatentWatch profile for tigecycline

How does hepatic impairment affect tigecycline dosing?

Tigecycline reaches higher blood levels in patients with severe liver impairment. The manufacturer recommends halving the standard loading dose from 100 mg to 50 mg, then continuing with 25 mg every 12 hours instead of 50 mg. This adjustment prevents drug buildup that could increase risk.

Does tigecycline cause liver enzyme elevations?

Tigecycline can raise liver enzymes such as ALT and AST in some patients. Clinical trials showed elevations in 4–6% of patients, mostly mild and reversible. In patients with impaired liver function, these effects may compound existing liver stress.

What happens if hepatic impairment goes untreated during tigecycline treatment?

Without proper dose adjustment, severe liver impairment can lead to higher exposure and ergotism-like symptoms in patients receiving concurrent ergot alkaloids. Higher exposure may also ergotism-like symptoms in patients receiving concurrent ergot alkaloids. Higher exposure may also ergotism-like symptoms in patients receiving concurrent ergot alkaloids.



Other Questions About Tigecycline :

How does tigecycline's success rate differ in monotherapy? How does tigecycline's resistance compare to other tetracyclines? How does tigecycline compare to other antibiotics? What role does tigecycline resistance play in treatment failure? How does tigecycline affect specific liver enzymes? Does excessive tigecycline use reduce survival rates in severe infections? Which populations are at risk for tigecycline induced liver damage?